ホーム > hoge > 10242
* I study here <a href=" http://transformando.org/thunderscream-drops.pptx ">is thunderscream safe</a> Amgen earlier this year approached Onyx with an offer of $120 a share for the company, whose primary attraction is a blood-cancer drug called Kyprolis. Onyx then tried to run an auction to get a better price, but ultimately appears to have been unable to find another party to pay more than Amgen in an acceptable time frame.
- ページ: [[hoge]]
- 投稿者: [[Crazyfrog]]
- 優先順位: ä½
- 状態: çæ
- カテゴリー: 1393043320
- 投稿日: 2015-10-30 (金) 13:15:05
- バージョン: 6
** メッセージ
I study here <a href=" http://transformando.org/thunderscream-drops.pptx ">is thunderscream safe</a> Amgen earlier this year approached Onyx with an offer of $120 a share for the company, whose primary attraction is a blood-cancer drug called Kyprolis. Onyx then tried to run an auction to get a better price, but ultimately appears to have been unable to find another party to pay more than Amgen in an acceptable time frame.
--------
#comment
IP:188.143.232.43 TIME:"2015-10-30 (金) 13:15:05" REFERER:"http://www.kazuwaya.jp/clubskin/?hoge" USER_AGENT:"Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.1; SV1)"
